Microporous Surface Layers for Implantable Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices often induce a foreign body response (FBR) that leads to the formation of a dense fibrous capsule, limiting their performance and lifespan, particularly in devices requiring continuous monitoring or data recording, and causing issues like capsular contracture in tissue implants.
Innovation Solution
The use of microporous surface layers with macrotopographic features, including interconnected pores and granular structures, to enhance bio-integration and reduce FBR by promoting tissue ingrowth and angiogenesis, thereby minimizing capsule thickness and improving device integration with surrounding tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If smooth and impermeable surfaces are used for implantable devices, then device manufacturing is simplified, but foreign body response is intensified leading to dense fibrous capsule formation
Solution Approach 1:
The patent applies porous materials by coating the implantable device surface with a microporous layer containing pores of specific sizes (small pores 0.5-10 μm, intermediate pores 10-50 μm, and large pores 50-200 μm). This porous structure allows macrophage penetration and colonization, fundamentally changing the surface properties from impermeable to permeable, thereby reducing foreign body response while maintaining manufacturability through established coating techniques.
Solution Approach 2:
The patent implements local quality by creating a heterogeneous pore size distribution across the surface coating, with different pore sizes positioned to serve different functions. The coating contains a mixture of small, intermediate, and large pores in specific proportions, allowing different regions of the coating to perform specialized roles in macrophage interaction and tissue integration.
2Object-affected harmful factors
If porous biomaterials with large pore sizes are used to allow macrophage penetration, then vascularity in capsule tissue increases, but pore geometry may not maximize angiogenic activity
Solution Approach 1:
The patent applies parameter changes by precisely controlling the pore size distribution within specific ranges (small pores 0.5-10 μm, intermediate pores 10-50 μm, large pores 50-200 μm) and their relative proportions (20-80% small pores, 10-50% intermediate pores, 10-30% large pores). These parameter optimizations maximize macrophage colonization and angiogenic cytokine release, thereby enhancing vascularity and angiogenic activity in the capsule tissue.
Solution Approach 2:
The patent implements composite materials by creating a multi-component porous coating system that combines different pore size categories within a single coating layer. The coating comprises a composite structure with small pores, intermediate pores, and large pores working synergistically, where each pore size category contributes differently to macrophage interaction and angiogenic response.
3Object-affected harmful factors
If dense fibrous capsule forms around implantable devices, then device is isolated from surrounding tissue, but device performance and operating life are limited
Solution Approach 1:
The patent applies porous materials by coating the implantable device surface with a microporous layer containing pores of specific sizes (small pores 0.5-10 μm, intermediate pores 10-50 μm, and large pores 50-200 μm). This porous structure allows macrophage penetration and colonization, fundamentally changing the surface properties from impermeable to permeable, thereby reducing foreign body response while maintaining manufacturability through established coating techniques.
4Object-affected harmful factors
If textured surfaces with roughness of 300μm periodicity are used, then capsular contracture incidence is reduced, but problem remains in 10 to 20% of surgeries
Solution Approach 1:
The patent applies porous materials by coating the implantable device surface with a microporous layer containing pores of specific sizes (small pores 0.5-10 μm, intermediate pores 10-50 μm, and large pores 50-200 μm). This porous structure allows macrophage penetration and colonization, fundamentally changing the surface properties from impermeable to permeable, thereby reducing foreign body response while maintaining manufacturability through established coating techniques.
Solution Approach 2:
The patent applies parameter changes by precisely controlling the pore size distribution within specific ranges (small pores 0.5-10 μm, intermediate pores 10-50 μm, large pores 50-200 μm) and their relative proportions (20-80% small pores, 10-50% intermediate pores, 10-30% large pores). These parameter optimizations maximize macrophage colonization and angiogenic cytokine release, thereby enhancing vascularity and angiogenic activity in the capsule tissue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microporous surface layers effectively reduce foreign body capsule thickness and density, enhancing the integration of implantable devices with tissue, improving their performance and longevity, and reducing the risk of complications such as capsular contracture and infection.
Implementation Method 1
porous biomaterials with pore sizes on the order of cellular dimensions have been shown to alter the FBR. For example, porous biomaterials with a pore size that is large enough to allow macrophage penetration
Implementation Method 2
porous biomaterials with a pore size that is large enough to allow macrophage penetration was shown to increase vascularity in the capsule tissue
Data Source
Figure 1
Figure 2
Figure 3
AI summary
This disclosure provides implantable devices coated with microporous surface layers with macrotopographic features that improve bio-integration at the interface of the implantable devices and the surrounding tissue.